Senate Finance Committee Issues Testimony From Tax Foundation President Bunn
May 20, 2023
May 20, 2023
WASHINGTON, May 20 -- The Senate Finance Committee issued the following written testimony by Tax Foundation President & CEO Daniel Bunn involving a hearing on May 11, 2023, entitled "Cross-Border Rx: Pharmaceutical Manufacturers and U.S. International Tax Policy":
* * *
Thank you for the opportunity to provide testimony on the international tax system. I am Daniel Bunn, President & CEO of Tax Foundation.
I am going to cover three topics in . . .
* * *
Thank you for the opportunity to provide testimony on the international tax system. I am Daniel Bunn, President & CEO of Tax Foundation.
I am going to cover three topics in . . .